MX2012010520A - Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. - Google Patents
Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.Info
- Publication number
- MX2012010520A MX2012010520A MX2012010520A MX2012010520A MX2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A
- Authority
- MX
- Mexico
- Prior art keywords
- oxidative stress
- treatment
- antioxidant composition
- reducing oxidative
- hormonal contraceptive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se describe una composición antioxidante para reducir el estrés oxidativo en sujetos que se someten a tratamiento con fármaco anticonceptivo hormonal; en particular, dicha composición ha demostrado ser especialmente conveniente ya que, además de ser sorprendentemente efectiva, es extremadamente bien tolerada por el cuerpo ya que contiene componentes naturales tales como catequinas del té verde, levadura de selenio, ácido alfalipoico, y coenzima Q10.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10425067A EP2364697A1 (en) | 2010-03-12 | 2010-03-12 | Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs |
PCT/EP2011/053680 WO2011110661A1 (en) | 2010-03-12 | 2011-03-11 | Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012010520A true MX2012010520A (es) | 2013-01-18 |
MX342417B MX342417B (es) | 2016-09-27 |
Family
ID=42537475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012010520A MX342417B (es) | 2010-03-12 | 2011-03-11 | Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20130251696A1 (es) |
EP (2) | EP2364697A1 (es) |
JP (1) | JP5852971B2 (es) |
CN (1) | CN102811714B (es) |
AU (1) | AU2011226037B2 (es) |
ES (1) | ES2587255T3 (es) |
MX (1) | MX342417B (es) |
WO (1) | WO2011110661A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2567695B1 (en) * | 2011-09-09 | 2016-10-26 | Cornelli Consulting S.A.S. Di Umberto Cornelli & C. | Antioxidant composition for reducing oxidative stress ascribable to treatment with hormonal contraceptives |
ITMI20130397A1 (it) * | 2013-03-15 | 2014-09-16 | Giuliani Spa | Composizione a base di flavonidi per uso farmaceutico, nutrizionale o cosmetico con potenziata azione antiossidante |
JP6771853B2 (ja) * | 2014-03-31 | 2020-10-21 | 小林製薬株式会社 | ビタミンb6含有組成物 |
RU2563178C1 (ru) * | 2014-07-11 | 2015-09-20 | государственное бюджетное образовательное учреждение высшего профессионального образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ТюмГМУ Минздрава России) | Способ профилактики оксидативного стресса на фоне применения гормональной контрацептивной рилизинг-системы |
WO2016065360A1 (en) * | 2014-10-24 | 2016-04-28 | Robert Shorr | Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1072265A1 (en) * | 1999-07-20 | 2001-01-31 | MEDIS S.r.l. Medical Infusion Systems | Use of plant polyphenols for treating iron overload |
US20050053560A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaton S.A | Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin |
US20100129467A9 (en) * | 2007-08-31 | 2010-05-27 | Albritton Iv Ford D | Nutritional supplement |
CN101433314B (zh) * | 2007-11-13 | 2012-05-30 | 蒋爱芳 | 一种具有抗疲劳、抗氧化功能的保健食品 |
CN102847153B (zh) * | 2008-01-10 | 2015-03-11 | 营养株式会社 | 用于改善高龄者的营养状态、降低发热次数和/或提高免疫能力的组合物 |
GB0802403D0 (en) * | 2008-02-08 | 2008-03-12 | Probiox Sa | Compositions for the treatment of oxidative stress |
CN101569414B (zh) * | 2008-04-29 | 2013-04-10 | 安琪酵母股份有限公司 | 一种富含酵母硒和酵母葡聚糖的组合物 |
-
2010
- 2010-03-12 EP EP10425067A patent/EP2364697A1/en not_active Withdrawn
-
2011
- 2011-03-11 CN CN201180013358.2A patent/CN102811714B/zh active Active
- 2011-03-11 ES ES11713715.8T patent/ES2587255T3/es active Active
- 2011-03-11 AU AU2011226037A patent/AU2011226037B2/en active Active
- 2011-03-11 EP EP11713715.8A patent/EP2544675B1/en active Active
- 2011-03-11 JP JP2012557495A patent/JP5852971B2/ja active Active
- 2011-03-11 US US13/583,873 patent/US20130251696A1/en not_active Abandoned
- 2011-03-11 WO PCT/EP2011/053680 patent/WO2011110661A1/en active Application Filing
- 2011-03-11 MX MX2012010520A patent/MX342417B/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU2011226037A1 (en) | 2012-10-11 |
EP2544675B1 (en) | 2016-06-01 |
US20130251696A1 (en) | 2013-09-26 |
EP2544675A1 (en) | 2013-01-16 |
WO2011110661A1 (en) | 2011-09-15 |
JP5852971B2 (ja) | 2016-02-03 |
CN102811714A (zh) | 2012-12-05 |
CN102811714B (zh) | 2016-08-03 |
JP2013522262A (ja) | 2013-06-13 |
MX342417B (es) | 2016-09-27 |
ES2587255T3 (es) | 2016-10-21 |
EP2364697A1 (en) | 2011-09-14 |
AU2011226037B2 (en) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015008114A (es) | Derivados de exendina-4. | |
GB2491327A (en) | Delayed prolonged drug delivery | |
EP4233545A3 (en) | Synergistic bacterial compositions and methods of production and use thereof | |
GB2491328A (en) | Immediate/delayed drug delivery | |
PH12015500688A1 (en) | Exendin-4 derivatives as dual glp1/glucagon agonists | |
WO2010083239A3 (en) | Therapeutic modulation of vaginal epithelium boundary lubrication | |
WO2010089128A3 (en) | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | |
IN2015DN02729A (es) | ||
WO2011069010A3 (en) | Amantadine compositions and methods of use | |
MY182983A (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
WO2012142413A3 (en) | Nitrite compositions and uses thereof | |
MX342417B (es) | Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. | |
MX2013011833A (es) | Formula infantil para ser usada en la prevencion de enfermedades cardiovasculares. | |
IN2014DN09383A (es) | ||
WO2012108748A3 (ko) | 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 | |
WO2011156820A9 (en) | Compositions, methods and uses for treatment of type 1 diabetes | |
MX336154B (es) | Tratamiento de atrofia vaginal en mujeres con riesgo de patologia tumoral. | |
WO2013188876A3 (en) | Methods for modulating kallikrein (klkb1) expression | |
WO2014031745A3 (en) | Materials and methods for modulating glucose uptake | |
MY159675A (en) | Clerodane derivatives for modulation of leukotriene receptor activity and related diseases | |
RU2012155738A (ru) | Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа | |
RU2012137549A (ru) | Композиция внутреннего применения для коррекции гормонального старения кожи | |
UA56226U (ru) | Способ лечения и профилактики послеоперационных рубцов у крыс, прооперированных по поводу нейрохирургической патологии, с использованием электрофореза препарата стекловидное тело | |
WO2011099721A3 (ko) | 수지상 세포의 성숙화 유도용 조성물 | |
UA56675U (ru) | Способ местного лечения генерализованного пародонтита c использованием синглетно-кислородной терапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |